Clinical Trial Update: A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation

View source ↗

Summary

Clinical trial update indicating the tegaserod tIND program in women with irritable bowel syndrome with constipation or chronic idiopathic constipation is no lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Zelnorm (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation | Status: NO_LONGER_AVAILABLE